Home NDC 66220-287 Caldolor
Product NDC 66220-287
11-digit product format 662200287
Labeler code 66220
Product ID 66220-287_5ae546e7-3ced-49f9-8f17-c0bb0776ae8a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ibuprofen
Dosage form INJECTION
Route INTRAVENOUS
Labeler Cumberland Pharmaceuticals Inc.
Application NDA022348
Marketing category NDA
Marketing start 2009-06-11
Substance IBUPROFEN
Active strength 800 mg/8mL
Pharmacologic classes Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022348-001 CALDOLOR IBUPROFEN 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 N022348-002 CALDOLOR IBUPROFEN 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 N022348-003 CALDOLOR IBUPROFEN 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25
Orange Book patents# Current patent rows page 1 of 1 · 14 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N022348-001 NPP 2026-05-11 N022348-002 NPP 2026-05-11 N022348-003 NPP 2026-05-11
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022348-002 CALDOLOR 800MG/8ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-11 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022348-003 CALDOLOR 800MG/200ML (4MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-01-25 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022348-001 CALDOLOR 400MG/4ML (100MG/ML) SOLUTION / INTRAVENOUS 2009-06-11 301d65b070ca…
Observed Orange Book patent history# Patent history page 1 of 15 · 568 observed states.
Observed Orange Book exclusivity history# Exclusivity history page 1 of 4 · 132 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Caldolor
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength IBUPROFEN 800 mg/8mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination WK2XYI10QM Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 854183 Internal RxNorm lookup 854187 Internal RxNorm lookup 2178273 Internal RxNorm lookup 2178275 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 66220-287-08 Caldolor 25 in 1 CARTON INJECTION 25 16 66220-287-08 Caldolor 8 mL in 1 VIAL INJECTION 8 16 66220-287-11 Caldolor 200 mL in 1 BAG INJECTION 200 16 66220-287-24 Caldolor 20 in 1 CASE INJECTION 20 16
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 66220-287 CALDOLOR (IBUPROFEN) INJECTION [CUMBERLAND PHARMACEUTICALS INC.] 16 Current NDC, Legacy NDC, 4 package rows 20250216_1eaa7790-f1a1-4f51-b10a-cbbaf033f684.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Caldolor IBUPROFEN Cumberland Pharmaceuticals Inc. 1eaa7790-f1a1-4f51-b10a-cbbaf033f684 2026-01-29 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 022348 application number: NDA022348 ndc (product): 66220-287
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 66220-287-08 66220028708 25 VIAL in 1 CARTON (66220-287-08) / 8 mL in 1 VIAL 25 vial 2009-06-11 0000-00-00 No No Current 66220-287-11 66220028711 200 mL in 1 BAG 200 ml Historical 66220-287-24 66220028724 20 in 1 CASE Historical